about
Myg1-deficient mice display alterations in stress-induced responses and reduction of sex-dependent behavioural differencesAltered renal morphology in transgenic mice with cholecystokinin overexpression.Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivoInterpretation of knockout experiments: the congenic footprint.Galanin receptors as a potential target for neurological disease.Recent in vivo advances in cell-penetrating peptide-assisted drug delivery.PEG shielded MMP sensitive CPPs for efficient and tumor specific gene delivery in vivo.Novel systemically active galanin receptor 2 ligands in depression-like behavior.Novel galanin receptor subtype specific ligand in depression like behavior.Cell-penetrating peptides, PepFects, show no evidence of toxicity and immunogenicity in vitro and in vivo.Magnetic Nanoparticle Assisted Self-assembly of Cell Penetrating Peptides-Oligonucleotides Complexes for Gene Delivery.Distinct changes in the behavioural effects of morphine and naloxone in CCK2 receptor-deficient mice.Targeted mutation of CCK(2) receptor gene antagonises behavioural changes induced by social isolation in female, but not in male mice.Deletion of the CCK2 receptor gene reduces mechanical sensitivity and abolishes the development of hyperalgesia in mononeuropathic mice.Optimization of in vivo DNA delivery with NickFect peptide vectors.PepFect14 peptide vector for efficient gene delivery in cell cultures.Wfs1-deficient mice display impaired behavioural adaptation in stressful environment.Stress-induced analgesia in mice: evidence for interaction between endocannabinoids and cholecystokinin.Effective in vivo gene delivery with reduced toxicity, achieved by charge and fatty acid -modified cell penetrating peptide.Formulation of Stable and Homogeneous Cell-Penetrating Peptide NF55 Nanoparticles for Efficient Gene Delivery In Vivo.Different housing conditions alter the behavioural phenotype of CCK(2) receptor-deficient mice.Environmental enrichment reduces mechanical hypersensitivity in neuropathic mice, but fails to abolish the phenotype of CCK2 receptor deficient mice.Porous silicon-cell penetrating peptide hybrid nanocarrier for intracellular delivery of oligonucleotides.Lower anxiety and a decrease in agonistic behaviour in Lsamp-deficient mice.Behavioural differences between C57BL/6 and 129S6/SvEv strains are reinforced by environmental enrichment.Gene expression profiling reveals upregulation of Tlr4 receptors in Cckb receptor deficient miceCPP-Based Delivery System for In Vivo Gene DeliveryRecent CPP-based applications in medicineThe future of peptides in cancer treatmentEffective lung-targeted RNAi in mice with peptide-based delivery of nucleic acidEnhancement of siRNA transfection by the optimization of fatty acid length and histidine content in the CPP
P50
Q28504882-51480F66-9114-41B9-8F53-E9D4AEA7F1F0Q33362401-C5803AC5-A938-4AF6-AEC8-95D86FE1AB46Q34946937-564DD61F-0B00-450D-BD60-D484FCF54858Q35839829-CD7AB355-2985-4B76-A353-80C25395BBB6Q38556483-D3B1F8EA-5D1C-432B-B33F-73BA2BD02511Q38658534-2154D195-D7F2-42D4-9956-59A19CFD9209Q38879790-47740158-1879-4898-A3F9-91736A01F1C2Q39163756-C35B4E3E-FDC3-44AB-B29B-8B767E7ADA14Q39236277-794C6CAA-A47E-4F66-B57C-1A078A8895E9Q39462401-96CE8856-7266-4B6A-B0B2-7A39F166BCD9Q41490579-34EDBFD3-A2FB-47DE-9235-EE4F901C88EFQ44567461-8F402452-7D3B-48CD-932D-5D8AC9C35A2AQ45027660-93BE7CDE-BF11-4F89-8DC0-AD2D5D834495Q45049916-7AD1B573-3534-4A8F-B1E9-CEBFD097F117Q45858582-3A0281A4-224A-4048-92C0-0A32C8243468Q45883365-D122E2D1-2331-4B83-9EAA-24B7883A7B5BQ46223218-C8267C23-F505-44BE-9931-B4983B1579A2Q46644678-FC3B5FF1-92FF-4C5B-94C2-D9427B55FE02Q47104050-70F4BB21-146A-4916-BEA4-8B954D715AEBQ47104585-24F7E415-A3FD-4D6B-8447-645DE33F2781Q48339256-835C35AB-FB70-4D59-B9BC-E9AE45CA5F26Q48429866-FDA672C7-236D-4CF0-9F5F-40DD62D77B53Q48906124-E833901C-B134-4563-8AA9-199E60FD1137Q50665032-97F28CBD-1371-4833-ACDB-6FCA997E885EQ51951323-32276506-AD20-4465-9713-D3DA5249C7D4Q57741906-F0CB84EA-59CC-4F99-B5A9-0E86844A0928Q85642674-3B54A20A-AAAC-446E-B0C7-78F06759161DQ90127648-13ACD849-DC52-4C56-8560-62F2C51F7085Q92270623-CF7DD0D5-4A94-4510-9490-69CA49C39C02Q92289756-28280532-2989-4FC3-9E5F-3BE87F443EC6Q92611446-81954EC5-600E-459A-A00D-BEFFD0319334
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Kaido Kurrikoff
@ast
Kaido Kurrikoff
@en
Kaido Kurrikoff
@es
Kaido Kurrikoff
@nl
Kaido Kurrikoff
@sl
type
label
Kaido Kurrikoff
@ast
Kaido Kurrikoff
@en
Kaido Kurrikoff
@es
Kaido Kurrikoff
@nl
Kaido Kurrikoff
@sl
prefLabel
Kaido Kurrikoff
@ast
Kaido Kurrikoff
@en
Kaido Kurrikoff
@es
Kaido Kurrikoff
@nl
Kaido Kurrikoff
@sl
P1053
D-1518-2010
P106
P1153
6507809944
P21
P2798
P31
P3829
P3835
kaido-kurrikoff
P496
0000-0002-5161-8930
P569
2000-01-01T00:00:00Z